Compare BEAM & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEAM | BFAM |
|---|---|---|
| Founded | 2017 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.6B |
| IPO Year | 2019 | 2012 |
| Metric | BEAM | BFAM |
|---|---|---|
| Price | $29.02 | $65.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | $50.75 | ★ $114.57 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.31 | 40.00 |
| EPS | N/A | ★ 0.62 |
| Revenue | $24,000.00 | ★ $1,903,182,000.00 |
| Revenue This Year | N/A | $8.19 |
| Revenue Next Year | $33.77 | $5.83 |
| P/E Ratio | ★ N/A | $105.34 |
| Revenue Growth | ★ 33.33 | N/A |
| 52 Week Low | $15.60 | $57.63 |
| 52 Week High | $36.44 | $130.76 |
| Indicator | BEAM | BFAM |
|---|---|---|
| Relative Strength Index (RSI) | 47.10 | 46.02 |
| Support Level | $26.96 | $64.34 |
| Resistance Level | $29.06 | $104.97 |
| Average True Range (ATR) | 2.12 | 2.78 |
| MACD | -0.21 | 0.79 |
| Stochastic Oscillator | 11.71 | 73.02 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.
Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; Full-service center-based child care, Backup care, and Educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.